Jaguar Health Inc reports results for the quarter ended September 30 - Earnings Summary

Jaguar Health

13/11/2024 14:17

* Jaguar Health Inc  JAGX.OQ  reported a quarterly adjusted
loss
of $1.05​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of $-33.00.  The lone analyst forecast for the quarter was for a
loss of $2.37 per share. 
    * Revenue rose 10.5% to $3.11 million from a year ago;
analysts
expected $3.94 million. 
    * Jaguar Health Inc's reported EPS for the quarter was a
loss of
$1.05​.
    * The company reported a quarterly loss of $9.85 million.
    * Jaguar Health Inc shares had fallen by 19.3% this
quarter and
lost 88.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 113.5% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Jaguar Health Inc
is 14.50 
This summary was machine generated from LSEG data November 13 at
02:17 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -2.37          -1.05          Beat
 Jun. 30 2024      -1.20                         
 Mar. 31 2024      -1.80          -4.20          Missed